Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Generic Industry Specialization, Consolidation Driven By Rising Product Complexity

Mar 04 2013

• By Derrick Gingery

Related Content

Biosimilar User Fee Meeting Schedule Allows FDA Data “Pre-Review”

Sep 17 2012

Biosimilar Players Will Be Manufacturers Large And Small, Analyst Predicts

Sep 26 2011

FDA Envisions Many Regulatory Coalitions Dealing With Globalization Issues

Sep 26 2011

Are Potential Biosimilar Sponsors Still Hesitant About The Pathway Despite Expected Growth?

Mar 04 2013

Hamburg Trumpets Potential Rewards Of Quality Improvement For Generic Industry

Feb 23 2013

Merck Partners With Korea’s Samsung Bioepis On Multiple Biosimilar Targets

Feb 20 2013

Mylan And India’s Biocon Team Up To Develop Insulin Biosimilars Of Sanofi, Lilly, Novo Nordisk Products

Feb 14 2013

Related Companies

Teva Pharmaceutical Industries Ltd.

Allergan plc

IQVIA Holdings Inc.

Viatris Inc.

Biocon, Ltd.

Merck & Co., Inc.

Samsung Bioepis Co., Ltd.

Novartis AG

Additional Topics

United States Advertising, Marketing & Sales Leadership BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window